All In Biotech

Drug Trial Radar · NCT01514929

A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers

A Randomized, Double-Blind, Placebo and Positive-Controlled, Crossover Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers

Last checked: Nov 20, 2026Latest source record: May 9, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

64

Actual

Start

Oct 2011

Primary completion

Not stated

Study completion Mar 2012

Sponsor

Lead sponsor
Achaogen, Inc.Industry
Sponsor type
Industry
Collaborators
Department of Health and Human Services
First posted
Jan 23, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if the study drug, ACHN-490 Injection, affects the QT interval in normal volunteers. The hypothesis is that the drug will not cause an increase in the QT interval.

Conditions

  • Cardiac Effects in Normal Healthy Volunteers

Interventions

  • ACHN-490 InjectionDrug

    20mg/kg IV 30 minute infusion given once

  • ACHN-490 InjectionDrug

    15mg/kg IV 30 minute infusion given once

  • MoxifloxacinDrug

    400mg oral pill given once

  • PlaceboDrug

    Placebo oral pill given once

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SafetyTime frame: 1 day
  2. Effect of ACHN-490 Injection on QTcFTime frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Investigational Site

    West Bend, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.